×
We recently upgraded the website!  If you run into any issues, please Contact Us.  We'd also love to hear your feedback!  Enjoy exploring the new site!

Sponsored Webcast: Health Canada XML PM: What We’ve Learned Since the July 18 Deadline (On Demand)

Member: $0 | Nonmember $50
This webcast will help you assess your XML PM strategy and stay compliant in a fast-evolving regulatory landscape.

NAMSA


The 18 July 2025, deadline for Health Canada’s mandatory XML Product Monograph (PM) submissions has come and gone — but what has the transition revealed about industry readiness, process challenges, and regulator expectations?

Join us for a post-deadline debrief where regulatory experts share key insights from the initial wave of XML PM submissions. We will explore common hurdles companies faced, lessons learned from successful implementations, and what’s next for those still catching up or preparing for future updates. Whether you submitted on time or are navigating late compliance, this session will provide valuable takeaways to strengthen your regulatory operations moving forward.

Registration Fees & Deadlines

Member: $0 | Nonmember $50

Learning Objective

  • Identify key insights and trends from the first wave of XML Product Monograph submissions.
  • Recognize common technical and regulatory challenges encountered during the transition to XML—and apply strategies to address them.
  • Apply best practices and recommendations for organizations submitting post-deadline or managing ongoing product monograph updates.
  • Interpret Health Canada’s feedback and enforcement posture to inform future XML PM submission planning and compliance efforts.

Who Should Attend?

Regulatory affairs professionals, medical writers, and digital publishing teams

Audience Learning Level

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.

Speakers

Leslie Cort

Gary Saner
LexisNexis Reed Tech, Sr. Regulatory Principal, Life Sciences

Leslie Cort

Mary Frasch
LexisNexis Reed Tech, Head of Regulatory Compliance Delivery

Leslie Cort

Dennis Lingg
LexisNexis Reed Tech, Regulatory Consultant